| [1] |
ZHANG Bolun, WANG Jia, ZHU Jiahe, XING Dehao, DING Gaoheng, LIU Yuqin.
Trends in incidence and mortality of prostate cancer in Gansu Pro-vince from 2010 to 2021 and its predictive analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 562-567.
|
| [2] |
TAO Hao, ZHOU Zihan, WEN Qiuping, QIU Moqin, CAO Ji, LI Qiulin, YU Hongping.
Trends in lung cancer incidence and mortality in Guangxi from 2011 to 2020
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(4): 421-246.
|
| [3] |
PANG Yifei, WANG Yaxi, GUO Ning, XING Jinliang, WANG Fuli, GUO Xu.
Evaluating the efficacy of urinary cell⁃free DNA in the diagnosis of malignant tumor: Extending from urological cancers to cross⁃system exploration
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(4): 496-501.
|
| [4] |
LU Jianling, WEI Chunhua, ZHOU Zihan, CAO Ji, LI Qiulin, TANG Xiaozhun, YU Hongping.
Epidemic characteristics of thyroid cancer in Guangxi cancer registration areas in 2019 and trends analysis from 2012 to 2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(2): 133-138.
|
| [5] |
PAN Hongxin, CUI Wangfei, LYU Licheng, WANG Xinzheng, CAO Ling, ZHANG Yongzhen.
Analysis of the incidence and mortality of malignant tumors in tumor registration areas of Shanxi Province,2020
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 700-706.
|
| [6] |
DONG Junling, YANG Hui, LI Na.
Trend of the incidence of gastric cancer in China,1992—2021
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 593-597.
|
| [7] |
SU Lili, LAN Zhenyu, LIN Huizhe, YAN Fangna, CHEN Weilian, LIN Wei.
Effects of sarcopenia on prognosis of prostate cancer treatment: a Meta-analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 487-493.
|
| [8] |
SUN Xiaoxia, WANG Yuping, SI Meili, ZHU Jing, ZHONG Mei.
Trends of incidence and mortality and the age-period-cohort of cervical cancer in China,1990—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 317-320.
|
| [9] |
QIN Liming, ZHOU Zihan, CAO Ji, LI Qiulin, YU Jiahua, RONG Minhua, ZHAO Libin, MAI Yuejiao, GE Lianying, QIN Yuzhou, YU Hongping.
Epidemiological characteristics and disease burden analysis of gastric cancer in Guangxi,2011—2018
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 172-178.
|
| [10] |
WANG Juwei, WANG Jing, MA Lijun, LI Zan .
Trends in the incidence and mortality of liver cancer in China based on the JoinPoint regression model,2000—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 180-185.
|
| [11] |
CHEN Lijun, LIANG Xiumei, WU Yun, LU Xiangning, XIE Ganglin, YANG Zhijun.
A survival report of 78,046 patients with malignant tumor from a hospital?based cancer registry database
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 229-237.
|
| [12] |
ZHOU Zihan, LI Qiulin, YU Jiahua, RONG Minhua, CAO Ji, GE Lianying, TANG Weizhong, YU Hongping.
Analysis of the epidemiological characteristics and disease burden of malignant tumors in Guangxi, 2019#br#
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 67-.
|
| [13] |
LIANG Xiumei, CHEN Weiyi, MA Liang, CHEN Lijun, GONG Wenfeng, YU Hongping, LIU Yingchun.
An analysis of hospitalized death cases of malignant tumors in a tertiary hospital in Guangxi from 2010 to 2020
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 662-666.
|
| [14] |
QIU Haiping, XIE Xiaoping, CHEN Tianqing.
A trend analysis of the incidence and mortality of lung cancer and an age-period-cohort model in China,1990—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 537-542.
|
| [15] |
LI Qiulin, YU Jiahua, RONG Minhua, ZHOU Zihan, CAO Ji, GE Lianying, YU Hongping, LIU Liang .
Epidemiological characteristics and the trend of disease burden of leukemia in children aged 0-14 years in Guangxi cancer registry areas,2015-2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 304-310.
|